The SH2/SH3 adapters Nck, Grb2 and Crk promote the assembly of signaling complexes by binding to tyrosine phosphorylated proteins using their SH2 domains and to proline-rich sequences on eector molecules using their SH3 domains. FGF, which activates a receptor tyrosine kinase, induces mesoderm formation in Xenopus embryos through activation of the Ras/Raf/MAPK signaling pathway. We present evidence that dominant-negative mutants of Nck and Grb2, but not Crk1, can inhibit mesoderm-speci®c gene induction by eFGF in Xenopus animal cap explants. We also show that dominantnegative mutants of Grb2 and Nck can inhibit eFGFinduced Erk1 activation in Xenopus animal caps, and that targeting the ®rst two SH3 domains of Nck to the membrane can activate Erk1 in the absence of eFGF. Furthermore, combinations of the dominant-negative Grb2 mutants with the inhibitory Nck mutant synergistically inhibited Erk1 activation by eFGF in Xenopus animal caps, suggesting that the dominant-negative Nck and Grb2 mutants inhibit Erk1 activation by binding to dierent proteins. By contrast only Grb2 mutants could inhibit eFGF-induced Erk1 activation in human 293 cells, demonstrating diversity in the speci®c mechanisms of signaling from FGF to MAP kinases in dierent cells.
Introduction
Src homology 2 and 3 (SH2 and SH3) domains are small modular domains that facilitate protein-protein interactions. SH2 domains bind speci®cally and with high anity to phosphotyrosine residues on interacting proteins, whereas SH3 domains bind to prolinerich sequences on target molecules (Cohen and Baltimore, 1995; Pawson, 1995) . Nck, Grb2 and Crk are members of a small family of adapter proteins that have no enzymatic activity and consist mostly of SH2 and SH3 domains. The binding speci®city and distribution within the adapters of these domains dier, however, suggesting dierences in the signals propagated by these adapters. Genetic studies on vulval development in C. elegans and on eye development in Drosophila have shown that Grb2 functions downstream of receptor tyrosine kinases and upstream of the small GTP-binding protein Ras (Clark et al., 1992; Olivier et al., 1993; Simon et al., 1993; Stern et al., 1993) . Grb2 binds via its two SH3 domains to a proline-rich region in Sos, a guanine nucleotide exchange factor for Ras. Activation of receptor tyrosine kinases therefore creates binding sites for the SH2 domain of Grb2, recruiting the Grb2-Sos complex to the plasma membrane, where Sos activates Ras. Activated Ras interacts with Raf, a serine/ threonine kinase that phosphorylates and activates MAPK kinase (MEK) (Dent et al., 1992; Hughes et al., 1993; Kyriakis et al., 1992; MacDonald et al., 1993) , which in turn phosphorylates Erk1 and Erk2 (MAPK) on threonine and tyrosine residues (Gomez and Cohen, 1991; Her et al., 1993; L'Allemain et al., 1992; Nakeilny et al., 1992; Rossomando et al., 1991) . Although Nck and Crk have also been reported to bind to Sos (Feller et al., 1995; Hu et al., 1995; Okada and Pessin, 1996; Teng et al., 1995) and might therefore also link activated tyrosine kinases to the Ras/Raf/MAPK signaling pathway, little is known about the relevance of this binding in vivo. Nck and Crk can also propagate signals through other mechanisms. It has been shown, for example, that Nck inhibits neural dierentiation of PC12 cells in a way that is independent of MAPK activation (Rockow et al., 1996) , and Crk can bind to C3G (Tanaka et al., 1994) , a guanine nucleotide exchange factor for Rap1 (Gotoh et al., 1995a) , a small GTPbinding protein closely related to Ras that was originally reported to be a tumor suppresser protein for v-Ki-Ras in NIH3T3 cells (Kitayama et al., 1989) .
Fibroblast growth factor (FGF), which activates a receptor tyrosine kinase (FGFR), stimulates cell proliferation by activation of the Ras/Raf/MAPK pathway (Fantl et al., 1993; Ullrich and Schlessinger, 1990) . Microinjection of RNA encoding dominantnegative mutants of Ras or Raf, or encoding a MAPKspeci®c phosphatase, into Xenopus embryos has also implicated Ras, Raf and MAPK in mesoderm induction by FGF (Gotoh et al., 1995b; LaBonne et al., 1995; MacNicol et al., 1993; Umbhauer et al., 1995; Whitman and Melton, 1992) . Although a peptide fragment of the chicken bFGFR was shown to bind to the SH2 domain of Grb2 with moderate anity (Ward et al., 1996) , intact FGFRs do not bind directly to SH2/SH3 adapter proteins. FGFR1 has no consensus binding sites for the SH2 domains of any of the SH2/SH3 adapters. A consensus binding site exists for the SH2 domain of PLCg but mutation of this site does not abolish FGF-induced ventral mesoderm formation in Xenopus, mitogenicity in myoblasts, or neurite outgrowth in PC12 cells (Mohammedi et al., 1992; Muslin, 1994; Peters et al., 1992) . Recently, a myristoylated protein of 90 ± 95 kDa termed FRS2 has been identi®ed which is tyrosine phosphorylated and binds to the Grb2/Sos complex in response to FGF stimulation, thus linking FGFR activation to stimulation of the Ras/Raf/MAPK pathway (Kouhara et al., 1997) . It has also been demonstrated that a complex containing Grb2, Nck and Sos can be co-immunoprecipitated with Xenopus FGFR1 (Ryan and Gillespie, 1994) . It is not known, however, whether Nck, like Grb2, propagates signals to activate MAPK in response to FGF stimulation, or whether it signals through a MAPK-independent mechanism.
Xenopus embryos provide a complex, physiological environment for the elucidation of roles for the adapters that may not be apparent in tissue culture. Xenopus embryonic FGF (eFGF) is a maternally expressed, secreted FGF that is present in blastula stage Xenopus embryos, during the time of mesoderm induction (Isaacs et al., 1992; Kimelman et al., 1988) . We have used a series of dominant-negative mutants of Nck, Grb2 and Crk1 in which the SH2 and/or the SH3 domains have been rendered inactive by introduction of point mutations that abolish binding to target proteins, to dissect the mechanism of Erk1 activation and mesoderm induction by eFGF. These constructs exert their eects by binding to and sequestering endogenous SH2-or SH3-binding proteins through their functional, unmutated domains. Thus, adapters with mutant SH2 domains would bind to and sequester SH3-domain binding proteins such as Sos, whereas adapters with mutant SH3 domains would prevent signaling by binding to tyrosinephosphorylated sites present on activated receptors or receptor substrates. Here we present evidence that endogenous Xenopus proteins that bind to Nck and Grb2, but not to Crk1, are involved in FGF-induced signaling in Xenopus. We also ®nd that the pro®le of inhibition of eFGF-induced Erk1 activation is dierent when 293 cells in tissue culture are compared with ectodermal explants of Xenopus embryos. a b Figure 1 Induction of Xbra, a mesoderm-speci®c gene, by eFGF is inhibited by mutants of Nck and Grb2. (a) Schematic representation of wild-type and DN SH2/SH3 adapters. Proteins are depicted to scale; SH2 and SH3 domains are represented as shaded boxes. Mutant domains in which binding activity has been ablated are indicated by X's. These mutants have previously been described in (Tanaka et al., 1995) . (b) The two ventral blastomeres of Xenopus embryos at the four-cell stage were microinjected with a total per embryo of 10 pg of pCS2BN or pCS2BN-eFGF DNA, in the absence or presence of 1.25 ng of WT or mutant Grb2 RNA or 1 ng of WT or mutant Nck or Crk1 RNAs, as indicated in the ®gure. Animal caps were dissected at stage 8 (mid-blastula) and cultured until undissected sibling embryos reached stage 10.25 (early gastrula). RNA was isolated from the animal caps and analysed by RT ± PCR for the expression of Xbra, a mesoderm-speci®c gene. The expression of EF1a, a ubiquitously expressed gene (Krieg et al., 1989) , was used as a loading control. Lanes labeled 7 or + RT indicate RT-PCR of RNA samples from uninjected whole embryos (WE) in which the cDNA synthesis was carried out in the absence or presence of reverse transcriptase (RT). AC=animal caps. We have previously determined by Western blot analysis that under these conditions similar levels of WT and mutant adapter proteins are expressed from injected RNA (Tanaka et al., 1997 and data not shown) . Results presented here are representative of at least three independent experiments
Results
Induction of Xbra, a mesoderm-speci®c gene, by eFGF is inhibited by DN mutants of Nck and Grb2
To analyse whether SH2/SH3 adapters can mediate intracellular signals initiated upon binding of FGF to its receptor in Xenopus laevis embryos, we used various dominant-negative (DN) SH2/SH3 mutants of the Nck, Grb2 and Crk1 adapter proteins (Figure 1a) . The point mutations that were introduced were designed to abolish detectable binding of ligand to the mutant domain without aecting the binding activity of the unmutated domains. We have previously shown that high-level expression of mutant adapters has DN eects upon cell signaling due to the binding and sequestering of phosphotyrosine sites in the case of the KSH3all mutants, or of eector proteins that bind to SH3 domains in the case of the KSH2 mutants (Tanaka et al., 1995) . KALL mutants, in which every SH2 and SH3 domain has been mutated, are unable to bind either upstream or downstream ligands, and therefore serve as better negative controls for non-speci®c eects of microinjection and protein expression than would microinjection in the absence of adapter RNA.
To determine the potential role of adapter binding proteins in the induction of mesoderm by FGF, we studied the eect of overexpression of DN adapters on the induction of a mesoderm-speci®c marker in animal pole explants (`animal caps') isolated from blastula stage embryos and cultured until the early-gastrula stage of development. When animal caps are cultured in the absence of any inducer, they dierentiate into ciliated epidermis. If the explants are stimulated with FGF, however, they dierentiate into ventral mesoderm such as mesenchyme and blood-like cells and express mesoderm-speci®c genes (Kimelman and Kirschner, 1987; Slack et al., 1987) . In vitro synthesized wild-type (WT) or mutant capped adapter mRNAs were microinjected along with DNA encoding Xenopus eFGF into the animal pole region of the two ventral blastomeres of four-cell stage embryos. Xenopus eFGF was injected as DNA because transcription from injected DNA occurs at the mid-blastula transition in Xenopus embryos, whereas translation from injected RNA is almost immediate (Vize et al., 1991 and data not shown). Thus, by the time cells of the animal hemisphere begin to ectopically express eFGF protein from the injected plasmid, which stimulates them to form ventral mesoderm, WT and mutant adapters are likely to have accumulated to levels capable of perturbing eFGF signaling. Also, since the inducer (eFGF DNA) and inhibitor (adapter RNA) are injected together, it is likely that every cell that inherits plasmid encoding eFGF will also have a large amount of the injected adapter RNA.
Animal caps from ventrally injected embryos were explanted at stage 8 (mid-blastula), and RT ± PCR analysis was used to study the induction of Xbra, a mesoderm-speci®c gene (Smith et al., 1991) . Overexpression of the WT or mutant adapters in the absence of DNA encoding eFGF did not induce mesoderm-speci®c gene expression in animal caps (data not shown). Overexpression of either GrbKSH2, GrbKSH3all or NckKSH2, however, inhibited the expression of Xbra mRNA induced by eFGF (Figure 1b) . In contrast, overexpression of the NckKSH3all or the DN Crk1 mutants did not inhibit Xbra induction by eFGF. The WT Nck and Grb2 adapters also inhibited Xbra induction by eFGF. Although this result was surprising, it is reminiscent of previous studies in which WT Nck was shown to inhibit the dierentiation of PC12 cells stimulated by basic FGF through a MAPK-independent mechanism (Rockow et al., 1996) . The inhibitory eect of the WT adapters in this case is most likely due to a`squelching' eect that prevents formation of a functional signaling complex: because the WT adapter protein expressed from injected RNA is likely to be present at much higher levels than endogenous proteins that bind to its SH2 or SH3 domains, some of the overexpressed WT adapter molecules might bind to upstream targets, others to downstream eectors, whereas only a few are likely to form the functional heterotrimeric signaling complex. The consensus from multiple experiments is that the inhibitory eect of NckKSH2, GrbKSH2 or GrbKSH3all on Xbra induction by eFGF is stronger than that of WT Nck or WT Grb2, and that WT Nck and WT Grb2 inhibit Xbra-induction by eFGF to a The two ventral blastomeres of four cell-stage Xenopus embryos were microinjected with either pCS2BN or pCS2BN-eFGF (10 pg per embryo), MTErk1 RNA (0.8 ng per embryo), and increasing amounts of RNA encoding NckKSH2, GrbKSH2 or GrbKSH3all. The indicated amounts of the non-functional NckKALL or GrbKALL RNAs were co-injected to maintain the same level of adapter RNA in each sample. Animal caps were cut from stage 8 embryos (mid-blastula), and lysed when sibling embryos reached stage 10.25 (early gastrula) rather than the late blastula stage as in Figure 2 . We ®nd that the inhibition of Erk1 activity by NckKSH2, GrbKSH2 or GrbKSH3all alone is stronger at stage 9 (late blastula) than at stage 10.25 (data not shown), so synergistic eects are not always apparent at the earlier stage due to complete inhibition of Erk1-kinase activity by these adapters. However, in experiments in which the inhibition is weaker at the earlier stage, synergistic eects are apparent at the earlier stage as well (data not shown). MT-Erk1 activity was measured by immune-complex kinase assay with the anti-Myc tag antibody 9E10. All adapter RNAs were transcribed from linearized pCS2BN vectors. The ®rst lane in both the right and left panels shows sample from animal caps isolated from uninjected embryos. Top panel: samples subjected to the kinase assay were resolved by SDS ± PAGE, and the top half of the gel was subjected to Western blot analysis with anti-Erk1 antibody (Santa Cruz Biotech.) to con®rm that equal amounts of MT-Erk1 were present in all samples in the immune-complex kinase assay. Second panel: relative phosphorylation of MBP. Third panel: Coomassie blue stained gel showing equal amounts of MBP substrate in all samples. Fourth and Fifth panels: Volumes of total cell lysates similar degree. Similar results were obtained for the inhibition of eFGF-induced expression of Xwnt8, a gene expressed in ventrolateral mesoderm (Christian et al., 1991) , but less strongly induced by eFGF than Xbra (data not shown). Thus, endogenous Xenopus proteins, which can bind to the Grb2 and Nck adapters, are required for the induction of mesodermspeci®c gene expression by eFGF.
Eect of DN adapters on Erk1 induction by eFGF in 293 cells and Xenopus animal caps
It has previously been shown that treatment of cells with growth factors such as FGF can result in the activation of MAPK (reviewed in Mason, 1994) . In an eort to understand the ability of Nck and Grb2 adapter mutants to block mesoderm-speci®c gene induction by eFGF in Xenopus animal caps, we initially examined the ability of adapter mutants to disrupt the activation of Erk1 by FGF in human 293 cells in tissue culture. We found that only the DN Grb2 mutants inhibited Erk1 activation by eFGF in 293 cells, while mutants of Nck and Crk1 had no detectable eect (data not shown). This pattern of inhibition is identical to that seen in our previous work using soluble EGF as the inducer (Tanaka et al., 1995) .
Several groups have shown that mesoderm induction by FGF in Xenopus embryogenesis requires activation of the MAPK pathway (Gotoh et al., 1995b; LaBonne et al., 1995; Umbhauer et al., 1995) . We considered two explanations for our ®nding that only DN Grb2 mutants could inhibit Erk1 activation in 293 cells (data not shown), while NckKSH2 as well as the DN Grb2 mutants could inhibit the induction of a mesodermspeci®c gene in Xenopus animal caps (Figure 1b) . It was possible that both Nck-binding and Grb2-binding proteins are required for activation of the MAPK pathway in animal caps but not in 293 cells; alternatively, there might be a MAPK-independent pathway to mesoderm-speci®c gene induction by eFGF that is mediated by Nck-binding proteins in animal caps. We therefore developed an assay to test MAPK activation in embryos injected with DN adapter RNAs. In vitro synthesized capped mRNA encoding WT or mutant adapters, and Myc epitope-tagged Erk1 (MTErk1) was coinjected either with empty vector DNA, or with DNA encoding eFGF into the two ventral blastomeres of the four-cell stage embryo. Animal caps were dissected from embryos grown to stage 8 (mid-blastula), cultured until late stage 9 (late blastula) and lysed. The amount of MT-Erk1 in the dierent samples was quantitated by Western blot analysis, and volumes of lysates containing equal amounts of MTErk1 were subjected to an immune complex kinase assay to measure Erk1 activity using MBP as a substrate. The eects of the DN adapters upon Erk1 activation by eFGF in animal caps were then compared, and the results of representative experiments are shown in Figure 2 .
We found that the pro®le of adapters that inhibited eFGF-induced Erk1 activation in animal caps ( Figure  2 ) was the same as that observed for inhibition of eFGF-induced mesoderm-speci®c gene expression (Figure 1b ). There was little or no induction of kinase activity in animal caps from uninjected embryos (lane 1), or from embryos microinjected with RNA encoding MT-Erk1 and vector DNA in the absence or presence of RNA encoding the non-functional KALL mutants of Nck or Grb2 (lanes 2 and 3). Erk1 activity was signi®cantly increased, however, upon microinjection of DNA encoding eFGF along with RNA encoding the control KALL mutants and MT-Erk1 (compare lanes 3 and 4). As mentioned previously for Xbra-induction by eFGF, we injected eFGF with RNA encoding KALL mutants since this is a better negative control for nonspeci®c eects of microinjection and protein expression than is microinjection of eFGF in the absence of any adapter RNA. Coinjection of GrbKSH2, GrbKSH3all, or NckKSH2 mutant RNAs with DNA encoding eFGF and MT-Erk1 RNA inhibited eFGF-induced Erk1 kinase activity. Erk1 activity induced by eFGF was also inhibited by WT Nck, and slightly by WT Grb2, most likely due to inecient formation of functional heterotrimeric signaling complexes, as mentioned above. Since the MAPK cascade has been implicated in mesoderm induction in Xenopus (Gotoh et al., 1995b; LaBonne et al., 1995; MacNicol et al., 1993; Umbhauer et al., 1995; Whitman and Melton, 1992) , inhibition of eFGF-induced Xbra expression by NckKSH2 and the DN Grb2 mutants (Figure 1b ) is likely to be due, at least in part, to the inhibitory eect of the mutants on Erk1 activation by eFGF.
Eect of combinations of DN Nck and Grb2 adapters upon eFGF-induced Erk1 activation in Xenopus animal caps
Since NckKSH2, GrbKSH2 and GrbKSH3all each inhibited mesoderm-speci®c gene induction and Erk1 activation in animal caps, we concentrated on these adapters and determined whether combinations of the Grb2 DN mutants with NckKSH2 could inhibit Erk1 activation by eFGF more eciently than any adapter alone. These experiments address whether the Nck and Grb2 adapters inhibit signaling by binding to the same or dierent proteins. Increasing amounts of NckKSH2 and Grb2 DN RNAs were transfected into the two ventral blastomeres of four-cell stage embryos, either alone or in combination, along with RNA encoding MT-Erk1 and DNA encoding eFGF. The ability of pairwise combinations of 0.1, 0.2, and 0.4 ng each of RNA encoding NckKSH2 and DN Grb2 mutants to inhibit eFGF-induced Erk1 activation was then assessed versus 0.2, 0.4 and 0.8 ng of each mutant alone. The total amount of adapter RNA injected into embryos was maintained at 0.8 ng by coinjecting appropriate amounts of non-functional NckKALL or corresponding to normalized levels of MT-Erk1 protein were subjected to Western blot analysis to con®rm the levels of Nck (fourth panel) and Grb2 (®fth panel) protein translated from the injected RNA, using anti-Nck and anti-Grb2 antibodies, respectively. (b) In vitro kinase data in (a) were quantitated and are presented graphically. The level of MBP phosphorylation in samples injected with pCS2BN-eFGF and the non-functional KALL adapter mutants was given an arbitrary value of 100. These results are representative of three independent experiments GrbKALL RNAs in order to maintain the same background environment in all samples. Results of representative experiments are shown in Figure 3 .
Microinjection of increasing amounts of NckKSH2 RNA caused a modest inhibition of approximately 40% of eFGF-induced Erk1-kinase activity in these experiments (Figure 3b ). Increasing amounts of either GrbKSH2 or GrbKSH3all inhibited eFGF-induced Erk1 activation more eciently than NckKSH2 (Figure 3b ). The combination of either NckKSH2 plus GrbKSH2, or NckKSH2 plus GrbKSH3all, however, was in all cases more eective in inhibiting eFGF-induced Erk1-kinase activity than was microinjection of any single adapter mutant (Figure 3b) , demonstrating a synergistic eect.
We also transfected increasing amounts of combinations of NckKSH2 and DN Grb2 adapters into 293 cells to determine whether this might reveal a cryptic requirement for Nck SH3 binding proteins in eFGFinduced Erk1 activation in these cells. We found that NckKSH2 did not synergize with the DN Grb2 adapters in inhibiting eFGF-induced Erk1 activation in 293 cells (data not shown). Taken together, our results suggest that DN Nck and Grb2 adapters perturb eFGF-induced signaling by binding to and sequestering dierent endogenous signaling molecules in Xenopus animal caps, and that the signaling mechanisms that activate Erk1 upon eFGF stimulation are more complex in Xenopus explants than in 293 cells in tissue culture.
Identi®cation of the Nck SH3 domains responsible for the inhibition of Erk1 activation by eFGF in Xenopus animal caps
The three SH3 domains of Nck can bind to dierent downstream signaling proteins (Chou and Hanafusa, 1995; Hu et al., 1995; Kitamura et al., 1996; Lu et al., 1997; Quilliam et al., 1996; Rivero-Lezcano et al., 1994 , 1995 . We have previously shown that ectopic expression of Nck constructs in which both the ®rst and second SH3 domains are intact leads to ventralization and anterior truncation of Xenopus embryos (Tanaka et al., 1997) . This suggests that proteins that bind to the ®rst and second SH3 domains of Nck are important for transmission of signals involved in Xenopus embryogenesis. We therefore determined which of the three Nck SH3 domains was responsible for the inhibitory eect of NckKSH2 upon eFGF-induced Erk1 activation in animal caps. The Nck mutants used in this analysis are depicted in Figure 4a . The two ventral blastomeres of Xenopus embryos at the four-cell stage were microinjected with either empty vector DNA or plasmid encoding eFGF and RNA encoding MT-Erk1 and mutant Nck RNAs. As in the previous experiments, microinjection of DNA encoding eFGF resulted in a signi®cant increase in Erk1 kinase activity (Figure 4b , compare lanes 1, 2 and 3), and this induction was inhibited by NckKSH2, (compare lanes 3 and 4). Of all other Nck RNAs with a mutant SH2 domain, only NckK229,308 inhibited eFGF-induced Erk1 activity, and this inhibition was on the same order of magnitude as that seen for NckKSH2 (lanes 3, 4, and 7). The NckK229 mutant, which unlike NckKSH2 or NckK229,308 contains a functional SH2 domain, also inhibited eFGF-induced Erk1 activation, although less eectively than NckK229,308. This may be because as with WT Nck, overexpression of NckK229 may prevent the ecient formation of signaling complexes containing both upstream and downstream eectors. Because no mutant in which either the ®rst or second SH3 domain was mutated could inhibit Erk1 activation by eFGF, we conclude that both the ®rst and the second SH3 domains of Nck are required to bind one or more proteins that mediate eFGF-induced Erk1 activation in Xenopus animal caps.
Eect of membrane localization of the ®rst two Nck SH3 domains on Erk1 activation in animal caps
One function of the adapters may be to recruit proteins which bind to their SH3 domains to the membrane because phosphotyrosine sites created upon activation of transmembrane tyrosine kinase receptors such as the FGFR would serve as binding sites for the SH2 domains of the adapters. Since NckK229,308 (in which only the ®rst two SH3 domains are intact) inhibited eFGF-induced Erk1 activation (Figure 4b ), we determined whether membrane localization of the ®rst two SH3 domains of Nck, in the absence of stimulation by eFGF, is sucient to activate Erk1 in Xenopus animal caps.
The two ventral blastomeres of Xenopus embryos at the four cell-stage were microinjected with reporter RNA encoding MT-Erk1, and with either RNA encoding the ®rst two SH3 domains of Nck [NckSH3(1+2)] or with RNA encoding myristoylated NckSH3(1+2) [Myr-NckSH3(1+2)] (see Figure 4a) . In Myr-NckSH3(1+2), the Src myristoylation signal (Myr) which constitutively targets proteins to the membrane (Pellman et al., 1985; Spencer et al., 1995) , is fused to the N-terminus of NckSH3(1+2). We ®nd that in transfected 293T or NIH3T3 cells, MyrNckSH3(1+2) protein localizes to the membrane, whereas NckSH3(1+2) is diusely cytoplasmic and nuclear (data not shown). We have previously shown that injection of Myr-NckSH3(1+2), but not NckSH3(1+2), into the dorsal blastomeres of four cell-stage embryos is sucient to ventralize Xenopus embryos (Tanaka et al., 1997) . We now ®nd that MyrNckSH3(1+2), but not NckSH3(1+2), can induce the kinase activity of MT-Erk1 in animal caps ( Figure 5) . Thus, localization of the ®rst two SH3 domains of Nck (and therefore endogenous Xenopus proteins that bind to these domains) to the membrane is sucient to activate the MAPK pathway in Xenopus.
Discussion
The SH2/SH3 adapter proteins Nck, Grb2 and Crk have no enzymatic activity and are involved in the assembly of signaling complexes upon activation of tyrosine kinases. FGFs bind to and activate receptor tyrosine kinases, and play an important role in the regulation of cell growth, dierentiation, embryogenesis and angiogenesis . In this study, we have used mutants of Nck, Grb2 and Crk1 to probe signaling pathways involved in eFGFinduced MAPK activation and mesoderm-speci®c gene induction in Xenopus animal cap explants.
We report that DN mutants of Grb2 as well as a Nck SH2 mutant could inhibit the induction of Xbra, a mesoderm-speci®c gene, by eFGF in Xenopus animal caps (Figure 1b) , whereas mutants of Crk1 had no inhibitory eect. This suggests that endogenous Xenopus proteins that can bind to the Nck and Grb2 adapters, but not to Crk, are required for the induction of mesoderm in Xenopus. It has previously been shown that mesoderm induction by FGF in Xenopus is mediated by the Ras/Raf/MAPK pathway (Gotoh et al., 1995b; LaBonne et al., 1995; MacNicol et al., 1993; Umbhauer et al., 1995; Whitman and Melton, 1992) . A role for Grb2 in the Ras/Raf/MAPK pathway has been shown by many groups (see Cohen and Baltimore, 1995; Pawson, 1995) , but the ability of Nck to propagate signals through this pathway is less well understood. It has been proposed that the binding of Nck to p130 cas upon stimulation of Src 7 cells with ®bronectin might facilitate signaling to Erk2 (Schlaepfer et al., 1997) . It has also been demonstrated that Nck can bind to Sos in vitro (Hu et al., 1995) potentially activating the Ras/Raf/MAPK pathway. On the other hand, PC12 cell dierentiation induced by basic FGF has been shown to be inhibited by Nck in a MAPK-independent mechanism (Rockow et al., 1996) . Furthermore, we have previously shown that, unlike Figure 5 Membrane localization of the ®rst two SH3 domains of Nck induces Erk1 kinase activity. The two ventral blastomeres of four cell-stage Xenopus embryos were microinjected with MTErk1 RNA (0.8 ng per embryo), and with 10 pg of either NckSH3(1+2) or Myr-NckSH3(1+2) RNAs transcribed from linearized pGHXP vectors, or with pCS2BN-eFGF (10 pg per embryo). The amounts of the Nck constructs microinjected in this experiment are lower than those used for Nck constructs in experiments shown in previous ®gures due to toxic eects of MyrNckSH3(1+2) at higher concentrations. Animal caps were explanted from stage 8 embryos, cultured until uninjected sibling embryos reached stage 9, and processed to assay MT-Erk1 activation as above. Results are representative of two experiments. Western blot analysis with anti-Nck antibody showed more NckSH3(1+2) than Myr-NckSH3(1+2) was present in the lysates from samples injected with RNA encoding these proteins, despite the inability of NckSH3(1+2) to induce MT-Erk1 kinase activity (data not shown). Western blot analysis with 9E10 antibody showed equal amounts of MT-Erk1 in the injected samples (data not shown) DN Grb2 mutants, DN Nck mutants did not perturb EGF-induced MAPK activation in 293 cells (Tanaka et al., 1995) , making it unlikely that Sos is a high-anity Nck target in vivo.
To clarify the role of Nck-binding proteins in MAPK activation, we tested the ability of mutant adapters to disrupt Erk1 activation by eFGF in Xenopus explants and in tissue culture cells. We found that in 293 cells, only mutants of Grb2, and not mutants of Nck or Crk1, could inhibit Erk1 activation by eFGF (data not shown). In Xenopus animal caps stimulated with eFGF, however, NckKSH2 as well as mutants of Grb2 could inhibit eFGF-induced Erk1 activation (Figure 2 ). This suggests there are dierences in the signaling mechanisms activated by eFGF in 293 cells and in Xenopus animal cap explants. The most likely explanation for these results is that there is at least one protein that binds the Nck SH3 domains which is important for MAPK activation by FGF in animal caps but not in 293 cells. Furthermore, since the pro®le of the adapter mutants which inhibit eFGFinduced Erk1 activation and mesoderm-speci®c gene induction in Xenopus animal caps is the same, the inhibitory eect of NckKSH2 and the DN Grb2 mutants on Xbra induction by eFGF is likely to be due to decreased stimulation of the Ras/Raf/MAPK pathway.
Since mutants of both Nck and Grb2 inhibited eFGF-induced Erk1 activation in Xenopus animal caps, we also used combinations of the inhibitory Nck and Grb2 adapters to determine whether they exert their eects by binding to the same sites on target proteins (Figure 3) . Because NckKSH3all has no inhibitory eect upon eFGF-induced Erk1 activation, whereas GrbKSH3all strongly inhibits, the two adaptors must bind to dierent upstream phosphotyrosine sites; only Grb2 SH2-binding sites are essential for signaling from eFGF to MAPK. Both NckKSH2 and GrbKSH2, however, inhibited eFGF-induced Erk1 activation in animal caps. If these two mutants block signaling by sequestering the same SH3-binding eector molecule (for example Sos), then combinations of the two mutants would not synergistically inhibit eFGFinduced Erk1 activation; the inhibitory eect of the combinations would be expected to be additive at best. If, however, NckKSH2 and the DN Grb2 mutants inhibit eFGF-induced Erk1 activation by binding to dierent proteins, then a combination of NckKSH2 with either GrbKSH2 or GrbKSH3all would be expected to give synergistic inhibition of eFGFinduced Erk1 activation in Xenopus animal caps.
We show that combinations of NckKSH2 with either GrbKSH2 or GrbKSH3all do in fact synergistically inhibit eFGF-induced Erk1 activation in animal caps (Figure 3) . Thus, inhibitory mutants of Nck and Grb2 must perturb eFGF-induced Erk1 activation by binding to dierent endogenous eector proteins in Xenopus animal caps. There was no synergistic inhibition, however, of eFGF-induced Erk1 activation in 293 cells transfected with combinations of DNA encoding NckKSH2 and either GrbKSH2 or GrbKSH3all (data not shown), consistent with the inability of Nck mutants alone to perturb MAPK activation by eFGF in 293 cells. This suggests that there are multiple pathways in Xenopus embryo cells that contribute to activation of Erk1 upon eFGF stimulation. Multiple signaling mechanisms from activated receptors might allow cells greater¯exibility in regulating the degree of MAPK activation upon stimulation with cytokines such as eFGF. This might be an advantage during early development where critical cell fate decisions depend on distinguishing relatively small quantitative or qualitative dierences in input signals.
Because our results suggest that Grb2 and Nck bind to dierent downstream eectors in Xenopus animal cap cells, we determined which of the three functional SH3 domains of NckKSH2 are required for the inhibitory eect of this mutant upon eFGF-induced Erk1 activation. Our results show that overexpression of both the ®rst and second SH3 domains of Nck inhibits eFGF-induced Erk1 activation in animal caps (Figure 4b ) and that membrane localization of the ®rst two SH3 domains of Nck is sucient to activate Erk1 in Xenopus animal caps ( Figure 5 ). This suggests that recruitment to the membrane of one or more proteins that bind to the ®rst and second SH3 domains of Nck is sucient to activate MAPK in the absence of a Grb2-mediated signal, and that DN Nck mutants inhibit eFGF-stimulated MAPK activation by sequestering this protein or proteins.
We have previously shown that expression of Nck constructs in which the ®rst two SH3 domains are still functional (WT Nck, NckKSH2, NckK229,308 and NckK229) could cause truncation of the anterior structures of Xenopus embryos (Tanaka et al., 1997) . Furthermore, microinjection of RNA encoding NckK229, the construct which had the most severe eect, into dorsal blastomeres of Xenopus embryos respeci®ed cells expressing this mutant to a more ventro-posterior fate and retarded the migration of presumptive anterior mesoderm cells during gastrulation (Tanaka et al., 1997) . This suggested to us that the ®rst two SH3 domains of Nck bind to endogenous proteins before or during gastrulation that aect mesoderm patterning. In this study, we have shown that overexpression of the ®rst two Nck SH3 domains perturbs MAPK activation by eFGF during blastula and early gastrula stages. The observation that two very dierent assays reveal a requirement for the ®rst two SH3 domains of Nck suggests an important role for proteins that can bind to these domains.
We cannot yet conclude whether anterior truncation and inhibition of MAPK activation arise from the same molecular mechanism. One important discrepancy between the earlier whole-embryo experiments and the results reported here is in the behavior of constructs encoding membrane-targeted NckSH3 (1+2). We have previously shown that microinjection of Myr-NckSH3(1+2) RNA into the dorsal blastomeres of four-cell Xenopus embryos caused a strong anterior truncation/ventralization phenotype, similar to but more severe than that seen with WT Nck and NckKSH2 (Tanaka et al., 1997) . However, in this study we show that Myr-NckSH3(1+2) activates MAPK, whereas WT Nck and NckKSH2 have an opposite, inhibitory eect on eFGF-stimulated MAPK activation. Furthermore, we ®nd that NckKSH2 and NckK229,308 are stronger inhibitors of eFGF-induced Erk1 activation than NckK229 (Figure 4b ), while NckK229 is the most potent of the three in causing anterior truncation in whole embryos (Tanaka et al., 1997) . It is possible that anterior truncation is due to perturbation of endogenous MAPK activation, and the discrepancies in the pattern of inhibition and stimulation by various mutants in the two systems is due to the dierent cells that give rise to the phenotypes (presumptive dorso-anterior mesoderm in whole embryos versus animal pole explants ectopically expressing eFGF). It is also possible that anterior truncation is due to sequestration of proteins that are not involved in MAPK activation but are required for transmission of other signals. To clarify these issues we are currently isolating and characterizing Xenopus proteins which bind to the ®rst two Nck SH3 domains to determine which downstream eectors are responsible for the observed biological eects of Nck and Nck mutants.
Materials and methods

Plasmids and antibodies
The pGHXP plasmid vector is a derivative of pGEM-HE, a gift of L Zon, (Children's Hospital, Boston, MA), and was used to generate mRNA encoding Nck mutants for microinjection in the experiments shown in Figures 4 and 5. pCS2+MT is an expression vector driven by the simian CMV IE94 promoter/enhancer for making Myc-tagged fusion proteins recognized by the 9E10 monoclonal antibody, and was a gift of D Turner and R Rupp (Hutchinson Cancer Research Center, Seattle, WA). pCS2MTBN was derived from pCS2+MT by sequentially destroying the original BamHI and NotI sites by ®lling in the ends of the sites generated by these restriction enzymes with the Klenow subunit of DNA polymerase I, and ligating the ends. A new BamHI site was then introduced between the EcoRI and XhoI sites, and a new NotI site was introduced between the XhoI and XbaI sites in polylinker I, to generate pCS2MTBN. pCS2MTBN is used to make Myc epitope-tagged fusion proteins. pCS2BN was generated by destroying the original NotI site and introducing a new one in polylinker I, as above. The DNA sequence encoding the Myc epitope-tag was then removed by digesting the vector with StuI and ClaI, end-®lling with Klenow and ligating the ends of the remaining plasmid DNA. pCS2BN was used to express proteins without the Myc epitope tag in experiments shown in Figures 1b, 2 , and 3. The entire coding region of rat Erk1 cDNA was cloned between the BamHI and NotI sites of pCS2MTBN to generate Myc epitope-tagged Erk1.
Polyclonal rabbit-anti-Erk1 (K-23) antibody was obtained from Santa Cruz Biotechnology. Anti-Grb2 and anti-Nck antibodies were generated by immunizing rabbits with full length GST-Grb2 or GST-Nck proteins, respectively, and anity puri®cation according to standard protocols (Harlow and Lane, 1988) .
Construction of DN SH2/SH3 adapters and in vitro transcription
To produce DN mutants of human Grb2 and Nck and chicken Crk, the conserved arginine of the FLVRES sequence in the SH2 domain was changed to lysine, or the ®rst (absolutely conserved) tryptophan of the characteristic tryptophan doublet of the SH3 domain was changed to lysine as described (Tanaka et al., 1995) . All mutants were cloned into pGHXP, sequenced in regions of primer binding, and were also subcloned into pCS2BN. In all cases, two independent PCR clones were characterized, and had identical properties. Capped synthetic RNAs were generated as described (Krieg and Melton, 1984) by in vitro transcription of linearized pCS2BN or pCS2MTBN using SP6 RNA polymerase, or from linearized pGHXP using T7 RNA polymerase with the mMessage mMachine kit (Ambion).
Embryos, microinjections and explant culture
Fertilized embryos were prepared as described (Newport and Kirschner, 1982) . Staging was according to Nieuwkoop and Faber (1967) . RNA was microinjected following published procedures (Newport and Kirschner, 1982) into the two ventral blastomeres of four-cell stage embryos. We chose this method because we found higher mesodermspeci®c gene expression as well as Erk1 activation in animal caps from embryos injected with DNA encoding eFGF into the ventral blastomeres compared with those from embryos injected into the dorsal blastomeres (data not shown). Results from embryos injected at the one-or two-cell stage would therefore be more variable depending upon the amount of injected material that became distributed into the future dorsal or future ventral sides of the embryo. The eect of WT or mutant adapters upon eFGF-induced gene expression and Erk1 activation in animal caps from dorsally or ventrally injected embryos was, however, qualitatively similar (data not shown). The site of sample injection was held within 30 ± 408 of the animal/vegetal axis running through the animal pole, and samples were always injected in a total volume of 5 nL per ventral blastomere in a 4-cell stage embryo, resulting in a total of 10 nL sample per embryo. Ectodermal explants (animal caps) comprising at most 20% of the top of the animal hemisphere were excised at stage 8 and cultured in 0.56 Marc's Modi®ed Ringer's (MMR: 0.1 M NaCl, 2 mM KCl, 1 mM MgSO 4 , 2 mM CaCl 2 , 5 mM HEPES [N-2-hydroxyethylpiperazine-N'2-ethane-sulfonic acid] pH 7.8, 0.1 mM EDTA) containing 0.5 mg/mL BSA. The mutant and WT adapter proteins are translated with comparable eciencies, and attain steady state concentrations that are stable for at least two days, as determined by Western blot analysis (data not shown).
RNA isolation and Reverse Transcriptase-PCR (RT ± PCR)
Total RNA was prepared from 10 animal cap explants or four whole embryos with Trizol reagent (GIBCO/BRL) according to the manufacturer's protocol and examined by RT ± PCR following standard procedures. Brie¯y, samples were quick frozen on dry ice and stored at 7808C until needed. 800 mL of Trizol reagent was then added, the sample vortexed until completely dissolved, and 160 mL of pure choloroform was then added to each sample. Samples were vortexed, and then microcentrifuged for 10 min at 48C. The top aqueous layer was transferred to a fresh tube, and the RNA was precipitated with 400 mL of isopropanol. The RNA samples were resuspended in RNAse-free water, and residual DNA in the samples was degraded with RNAse-free DNAse (GIBCO/BRL). The RNA sample was then re-precipitated with LiCl added to a ®nal concentration of 2M, and overnight incubation at 7208C. cDNA was synthesized from volumes of RNA samples corresponding to 4 animal caps or 0.2 whole embryos with Superscript II RT (GIBCO/BRL) according to the manufacturer's protocol for 1 ± 1.5 h at 428C. Volumes of RT reactions corresponding to 0.4 animal caps or 0.02 embryos were then subjected to PCR with primers speci®c for Xbra and EF1a. PCR reactions were performed in a 25 mL total volume, in the presence of trace amounts of [a-32 P]dCTP using an annealing temperature of 558C and 20 cycles for EF1a and 25 cycles for Xbra. This number of PCR cycles was determined to be within the linear range of ampli®cation using RNA extracted from whole embryos at the gastrula stage as template for RT ± PCR (data not shown). Sequences for the primer pairs used for RT ± PCR will be gladly provided upon request.
Immune-complex kinase assay in animal caps
Xenopus embryos injected with inducer DNA (pCS2BN-eFGF), adapter RNAs and reporter RNA (transcribed from pCS2MTBN-Erk1) were cultured to stage 8. 7 ± 10 animal caps were explanted as described above, cultured until late stage 9 or stage 10.25, and lysed in Triton lysis buer (25 mM Tris [pH 7.4], 150 mM NaCl, 5 mM Na 2 EDTA, 1% Triton X-100, 10 mM sodium pyrophosphate, 10 mM b-glycerophosphate, 1 mM Na 3 VO 4 , 10% glycerol, 1 mM phenylmethylsulfonyl¯uoride, 20 mg/mL aprotinin). Lysates were cleared by centrifugation at 10 000 g for 10 min. The amount of Myc epitope-tagged Erk1 (MT-Erk1) protein in each sample was determined by quantitative Western blot analysis. Brie¯y, after determining the linear range for detection with this procedure (data not shown), 0.2 animal caps equivalent of lysate was resolved by SDS ± PAGE and transferred to nitrocellulose membranes. The membranes were sequentially probed with the anti-Myc antibody 9E10 (Santa Cruz Biotechnology), biotinylated goat anti-mouse IgG (Pierce) and 35 Sstreptavidin (Amersham) and exposed to a phosphor screen. The relative amount of MT-Erk1 in each sample was then determined by quantitation on a Phosphorlmager (Molecular Dynamics). Volumes of sample lysates containing equal amounts of MT-Erk1 were then subjected to an immune complex kinase assay. This normalization for MTErk1 levels was always relatively small (less than three fold). Lysates were incubated with 1 mg 9E10 for 1 h at 48C, and then with protein A-sepharose beads bound to horse anti-mouse IgG (Pierce) for 1 h while rotating at 48C. Bound proteins were washed 36 in Triton lysis buer, 26 in kinase buer (50 mM HEPES pH 7.5, 10 mM MgCl 2 ), and then incubated in kinase buer containing 10 mCi of [g-32 P]ATP, 100 mM ATP and 0.2 mg/mL of myelin basic protein (MBP; Sigma) in a ®nal volume of 15 mL at 308C for 15 min. Reactions were stopped by the addition of 4 mL 56 Laemmli sample buer, boiled for 3 min and separated by SDS ± PAGE. Immunoblotting using rabbit anti-Nck or rabbit anti-Grb2 antibodies was performed according to standard protocols on volumes of lysates determined to contain equal amounts of MT-Erk1 to determine the relative levels of protein translated from the injected adapter RNAs in dierent samples.
